Novartis AG NVS
$162.55 +$0.62 (+0.38%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $162.55 0.00%
Open$159.40
Prev close$161.93
Day range$159.36 – $163.11
Volume2.00M
Market cap$307.00B
P/E (TTM)31.0
Dividend yield2.92%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$15.03B+4.7% YoY
Operating profit$1.84B-59.1% YoY
Net profit$1.20B-69.6% YoY
Diluted EPS$0.63-68.8% YoY
Free cash flow$4.76B-17.1% YoY
Operating cash flow$5.50B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin74.9%
Operating margin25.2%
Net margin17.5%
Return on equity24.6%
Return on assets8.9%
Return on invested capital13.9%
Current ratio0.88
Liabilities / assets67.9%
Cash & investments$8.98B
Total debt$48.03B
Net cash (debt)-$39.06B
Free cash flow / sales24.4%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $15.03B | $14.95B | $13.52B | $56.67B | $13.86B |
| Cost of Revenue | $3.61B | $3.71B | $3.46B | $13.70B | $3.61B |
| Gross Profit | $11.42B | $11.24B | $10.07B | $42.98B | $10.25B |
| Operating Expense | $9.58B | $6.49B | $5.83B | $25.33B | $6.63B |
| Selling and Admin Expenses | $3.08B | $3.24B | $3.14B | $13.25B | $3.44B |
| Research & Development | $5.15B | $2.85B | $2.74B | $11.20B | $3.16B |
| Other Operating Expenses | $1.35B | $403.00M | -$50.00M | $883.00M | $30.00M |
| Operating Profit | $1.84B | $4.75B | $4.24B | $17.64B | $3.62B |
| Net Non-Operating Interest Income (Expense) | -$523.00M | -$479.00M | -$393.00M | -$980.00M | -$96.00M |
| Non-Operating Interest Expense | $468.00M | $462.00M | $343.00M | $1.14B | $304.00M |
| Total Other Finance Costs | $55.00M | $17.00M | $50.00M | $209.00M | $165.00M |
| Other Income (Expense) | -$3.00M | -$2.00M | -$3.00M | -$312.00M | -$302.00M |
| Earnings from Equity Interest | -$3.00M | -$2.00M | -$3.00M | -$12.00M | -$2.00M |
| Pretax Profit | $1.32B | $4.27B | $3.84B | $16.35B | $3.22B |
| Tax | $121.00M | $1.01B | $683.00M | $2.39B | $814.00M |
| Net Profit | $1.20B | $3.26B | $3.16B | $13.97B | $2.40B |
| Profit from Continuing Operations | $1.20B | $3.26B | $3.16B | $13.97B | $2.40B |
| Minority Interests | -$6.00M | -$7.00M | $0.00 | -$17.00M | -$5.00M |
| Net Income to Parent Company | $1.20B | $3.26B | $3.16B | $13.98B | $2.41B |
| Net Income to Common Stockholders | $1.20B | $3.26B | $3.16B | $13.98B | $2.41B |
| Basic EPS | $0.63 | $1.71 | $1.65 | $7.21 | $1.26 |
| Diluted EPS | $0.63 | $1.71 | $1.65 | $7.15 | $1.25 |
| Dividend Per Share | $0.00 | $0.00 | $4.74 | $3.99 | $0.00 |
| Non-Operating Interest Income | – | – | – | $373.00M | – |
| Gain on Sale of Security | – | – | – | -$300.00M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $117.15B | $122.03B | $118.53B | $110.95B | $110.95B |
| Total Current Assets | $28.75B | $27.35B | $26.61B | $30.46B | $30.46B |
| Cash and Cash Equivalents & Short-Term Investments | $8.98B | $7.69B | $6.98B | $11.53B | $11.53B |
| -Cash and Cash Equivalents | $8.87B | $7.62B | $6.88B | $11.44B | $11.44B |
| -Short Term Investments | $105.00M | $74.00M | $100.00M | $98.00M | $98.00M |
| Receivables | $9.96B | $9.85B | $9.60B | $10.93B | $10.93B |
| -Accounts Receivable | $9.78B | $9.64B | $9.39B | $8.94B | $8.94B |
| -Taxes Receivable | $183.00M | $218.00M | $216.00M | $755.00M | $755.00M |
| Inventory | $6.10B | $6.22B | $6.29B | $6.27B | $6.27B |
| Other Current Assets | $3.71B | $3.59B | $3.74B | $514.00M | $514.00M |
| Total Non-Current Assets | $88.40B | $94.68B | $91.93B | $80.49B | $80.49B |
| Net PPE | $12.27B | $12.27B | $12.24B | $12.35B | $12.35B |
| -Gross PPE | $12.27B | $12.27B | $12.24B | $25.08B | $25.08B |
| Investments and Advances | $2.10B | $2.37B | $2.43B | $1.09B | $1.09B |
| -Long Term Equity Investment | $63.00M | $69.00M | $100.00M | $98.00M | $98.00M |
| Goodwill and Other Intangible Assets | $67.00B | $68.84B | $67.03B | $54.98B | $54.98B |
| -Goodwill | $27.18B | $26.77B | $26.82B | $25.57B | $25.57B |
| -Other Intangible Assets | $39.83B | $42.07B | $40.21B | $29.41B | $29.41B |
| Non-Current Deferred Assets | $5.35B | $5.28B | $5.25B | $5.98B | $5.98B |
| Other Non-Current Assets | $1.69B | $5.93B | $4.98B | $509.00M | $509.00M |
| Total Liabilities | $79.59B | $80.09B | $79.61B | $64.40B | $64.40B |
| Total Current Liabilities | $32.53B | $31.75B | $31.37B | $27.28B | $27.28B |
| Payables | $6.90B | $6.57B | $6.13B | $7.04B | $7.04B |
| -Accounts Payable | $4.24B | $4.26B | $4.32B | $4.46B | $4.46B |
| -Total Tax Payable | $2.65B | $2.31B | $1.81B | $2.58B | $2.58B |
| Short-Term Debt and Capital Lease Obligation | $9.93B | $9.86B | $7.89B | $5.78B | $5.78B |
| -Current Debt | $9.65B | $9.59B | $7.62B | $5.52B | $5.52B |
| -Current Capital Lease Obligation | $278.00M | $274.00M | $271.00M | $263.00M | $263.00M |
| Other Current Liabilities | $15.70B | $15.32B | $17.36B | $296.00M | $296.00M |
| Total Non-Current Liabilities | $47.06B | $48.34B | $48.23B | $37.12B | $37.12B |
| Long Term Debt and Capital Lease Obligation | $38.38B | $39.15B | $39.11B | $29.59B | $29.59B |
| -Long Term Debt | $36.70B | $37.49B | $37.45B | $27.94B | $27.94B |
| -Long Term Capital Lease Obligation | $1.68B | $1.66B | $1.66B | $1.66B | $1.66B |
| Non-Current Deferred Liabilities | $4.40B | $5.29B | $5.10B | $3.40B | $3.40B |
| Other Non-Current Liabilities | $4.28B | $3.90B | $4.02B | $957.00M | $957.00M |
| Total Equity | $37.56B | $41.95B | $38.93B | $46.55B | $46.55B |
| Stockholders' Equity | $37.23B | $41.54B | $38.51B | $46.13B | $46.13B |
| Capital Stock | $736.00M | $736.00M | $736.00M | $766.00M | $766.00M |
| -Common Stock | $736.00M | $736.00M | $736.00M | $766.00M | $766.00M |
| Retained Earnings | $39.24B | $39.65B | $37.25B | – | – |
| Less: Treasury Stock | $54.00M | $49.00M | $47.00M | $50.00M | $50.00M |
| Gains/Losses Not Affecting Retained Earnings | -$2.69B | $1.21B | $571.00M | $45.41B | $45.41B |
| Minority Interests | $336.00M | $404.00M | $415.00M | $419.00M | $419.00M |
| -Other Receivables | – | – | – | $1.24B | $1.24B |
| Prepaid Assets | – | – | – | $1.15B | $1.15B |
| -Accumulated Depreciation | – | – | – | -$12.73B | -$12.73B |
| -Available for Sale Securities | – | – | – | $465.00M | $465.00M |
| Non Current Accounts Receivables | – | – | – | $1.36B | $1.36B |
| Defined Pension Benefit | – | – | – | $4.23B | $4.23B |
| Current Accrued Expenses | – | – | – | $2.48B | $2.48B |
| Current Provisions | – | – | – | $9.43B | $9.43B |
| Non-Current Liabilities | – | – | – | $612.00M | $612.00M |
| Employee Benefits | – | – | – | $2.56B | $2.56B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $5.50B | $5.88B | $3.68B | $19.14B | $2.26B |
| Net cash flow from continuing operations | $5.50B | $5.88B | $3.68B | $19.14B | $2.26B |
| Net Income from Continuing Operations | $1.20B | $3.26B | $3.16B | $13.97B | $2.40B |
| Gain/Loss from Continuing Operations | $97.00M | -$245.00M | -$156.00M | $128.00M | $82.00M |
| Depreciation & Depletion & Amortization | $3.58B | $1.40B | $1.23B | $5.33B | $1.55B |
| Deferred Tax | $121.00M | $1.01B | $683.00M | $2.39B | $814.00M |
| Other Non-Cash Items | $72.00M | $179.00M | $104.00M | $19.00M | -$373.00M |
| Change in Working Capital | -$55.00M | $232.00M | -$787.00M | -$1.58B | -$1.59B |
| -Change in Receivables | -$170.00M | -$256.00M | -$504.00M | -$1.12B | -$94.00M |
| -Change in Inventory | $32.00M | $30.00M | -$95.00M | $34.00M | $151.00M |
| -Change in Payables and Accrued Expense | $41.00M | -$184.00M | -$53.00M | -$273.00M | $102.00M |
| -Change in Other Current Assets | $32.00M | $22.00M | $346.00M | -$461.00M | -$601.00M |
| -Change in Other Current Liabilities | $10.00M | $620.00M | -$481.00M | $247.00M | -$1.15B |
| Net cash flow from investing | -$1.75B | -$3.11B | -$11.74B | -$4.88B | -$2.10B |
| Net Cash Flow from Continuing Investing Activities | -$1.75B | -$3.11B | -$11.74B | -$4.88B | -$2.10B |
| Net PPE Purchase and Sale | -$392.00M | -$295.00M | -$341.00M | -$1.54B | -$608.00M |
| Net Intangibles Purchase and Sale | -$350.00M | -$437.00M | -$461.00M | -$2.19B | -$296.00M |
| Net Business Purchase and Sale | -$1.07B | -$2.68B | -$12.04B | -$3.00B | -$1.17B |
| Net Investment Purchase and Sale | $66.00M | $90.00M | $1.11B | $1.87B | -$18.00M |
| Net Other Investing Changes | -$3.00M | $218.00M | -$3.00M | -$24.00M | -$14.00M |
| Financing Cash Flow | -$2.46B | -$2.02B | $3.58B | -$14.87B | $1.68B |
| Net Cash Flow from Continuing Financing Activities | -$2.46B | -$2.02B | $3.58B | -$14.87B | $1.68B |
| Net Issuance Payments Of Debt | -$768.00M | $2.10B | $11.57B | $2.43B | $3.28B |
| Net Common Stock Issuance | -$1.70B | -$1.20B | -$1.88B | -$9.21B | -$1.48B |
| Net Other Financing Charges | $2.00M | -$67.00M | $78.00M | -$267.00M | -$97.00M |
| Ending Cash Balance | $8.87B | $7.62B | $6.88B | $11.44B | $11.44B |
| Net Change in Cash | $1.29B | $757.00M | -$4.48B | -$600.00M | $1.84B |
| Beginning Cash Balance | $7.62B | $6.88B | $11.44B | $11.46B | $9.56B |
| Effect of Exchange Rate Changes | -$39.00M | -$18.00M | -$77.00M | $576.00M | $36.00M |
| Free Cash Flow | $4.76B | $5.12B | $2.87B | $15.24B | $1.25B |
| Cash Dividends Paid | – | -$2.87B | -$6.20B | -$7.82B | $0.00 |
| Proceeds from Stock Option Exercised | – | $14.00M | – | – | – |
No comments yet — be the first to weigh in on NVS.
Sign in to join the discussion.